pharmaglobenews, Author at Pharma Globenewswire

Achondroplasia Market Insights, Epidemiology, and Market Forecast 2036

DelveInsight’s “Achondroplasia Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of the Achondroplasia, historical and forecasted epidemiology as well as the Achondroplasia market trends in the United States, EU4 (Germany, Spain, Italy, and France), United Kingdom, and Japan. Key

4 May 2026

Uncategorised

Preeclampsia Market Insights, Epidemiology, and Market Forecast 2036

DelveInsight’s “Preeclampsia Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of the Preeclampsia, historical and forecasted epidemiology as well as the Preeclampsia market trends in the United States, EU4 (Germany, Spain, Italy, and France), United Kingdom, and Japan. Key

1 May 2026

Uncategorised

Interleukin-2 (IL-2) Market: Global Trends, Epidemiology, Drug Pipeline, and Forecast Analysis Through 2034

Interleukin-2 (IL-2) Market Summary The Interleukin-2 market is witnessing a significant surge driven by growing interest in cancer immunotherapy, autoimmune disease management, and next-generation cytokine engineering. In 2023, the IL-2 market size was highest in the US among the 7 Major Markets

1 May 2026

Uncategorised

Bacterial Vaginosis Market Insights, Epidemiology, and Market Forecast 2034

DelveInsight’s “Bacterial Vaginosis Market Insights, Epidemiology, and Market Forecast 2034” report delivers an in-depth understanding of the Bacterial Vaginosis, historical and forecasted epidemiology as well as the Bacterial Vaginosis market trends in the United States, EU4 (Germany, France, Italy, and Spain), United

30 April 2026

Market Insights·Reports

Cardiac Monitoring Devices Market to Reach USD 31.6 Billion by 2032

The global demand for advanced cardiac monitoring technologies is witnessing steady momentum as healthcare systems increasingly prioritize early detection, continuous monitoring, and remote patient management for cardiovascular diseases. According to DelveInsight’s latest market intelligence report, the Cardiac Monitoring Devices market is projected

30 April 2026

Uncategorised

Thymidine Kinase 2 Deficiency Market Set for Explosive Growth: FDA Approval of KYGEVVI Sparks a New Era of Targeted Mitochondrial Disease Therapies Through 2034

Thymidine Kinase 2 Deficiency Market The Thymidine Kinase 2 Deficiency market is on the cusp of a remarkable transformation. According to the latest Thymidine Kinase 2 Deficiency market research, the market across the 7 Major Markets (7MM) is expected to grow from

29 April 2026

Uncategorised

Dermatomyositis Market Set to Advance with Improved Diagnosis and Emerging Immunotherapies by 2034 | Says DelveInsight

Dermatomyositis is a rare, chronic, inflammatory myopathy characterized by progressive muscle weakness and distinctive skin rashes, often associated with autoimmune mechanisms. It can occur in both adults and children and may involve complications such as interstitial lung disease, malignancy, and calcinosis. Despite

29 April 2026

Uncategorised

Cocaine Use Disorder Pipeline Appears Robust With 12+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Cocaine Use Disorder Pipeline Appears Robust With 12+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight DelveInsight’s, “Cocaine Use Disorder Pipeline Insight, 2025,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Cocaine Use Disorder pipeline

29 April 2026

Uncategorised

Chronic Spontaneous Urticaria Market Size in the 7MM was ~USD 2000 million in 2023, is expected to grow a significant CAGR by 2034, estimates DelveInsight

Chronic Spontaneous Urticaria Market DelveInsight’s “Chronic Venous Insufficiency Market Insight, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of Chronic Venous Insufficiency, historical and forecasted epidemiology as well as the Chronic Venous Insufficiency market trends in the United States,

29 April 2026

Market Insights·Reports

Complement 3 Glomerulopathy (C3G) Market Forecast 2034

The Complement 3 Glomerulopathy (C3G) market is poised for significant growth, driven by a deeper understanding of complement pathway dysregulation, improved diagnostic capabilities, and the introduction of novel targeted therapies such as Factor B inhibitors, C3 inhibitors, MASP-3 inhibitors, and RNA interference-based

29 April 2026

pharmaglobenews

Achondroplasia Market Insights, Epidemiology, and Market Forecast 2036

Preeclampsia Market Insights, Epidemiology, and Market Forecast 2036

Interleukin-2 (IL-2) Market: Global Trends, Epidemiology, Drug Pipeline, and Forecast Analysis Through 2034

Bacterial Vaginosis Market Insights, Epidemiology, and Market Forecast 2034

Cardiac Monitoring Devices Market to Reach USD 31.6 Billion by 2032

Thymidine Kinase 2 Deficiency Market Set for Explosive Growth: FDA Approval of KYGEVVI Sparks a New Era of Targeted Mitochondrial Disease Therapies Through 2034

Dermatomyositis Market Set to Advance with Improved Diagnosis and Emerging Immunotherapies by 2034 | Says DelveInsight

Cocaine Use Disorder Pipeline Appears Robust With 12+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Chronic Spontaneous Urticaria Market Size in the 7MM was ~USD 2000 million in 2023, is expected to grow a significant CAGR by 2034, estimates DelveInsight

Complement 3 Glomerulopathy (C3G) Market Forecast 2034

Recent Posts

Banner

Newsletter

Authors